Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark C Walters

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Annals of the New York Academy of Sciences|December 13, 2005
Sibling donor cord blood transplantation for thalassemia major: Experience of the Sibling Donor Cord Blood ProgramMark C Walters, Lynn Quirolo, Elizabeth T Trachtenberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2017
Relationship between Mixed Donor-Recipient Chimerism and Disease Recurrence after Hematopoietic Cell Transplantation for Sickle Cell DiseaseAllistair Abraham, Matthew Hsieh, Mary Eapen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2003
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemiaRobert Iannone, James F Casella, Ephraim J Fuchs, et al.
Blood Advances|October 7, 2024
Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell diseaseTami D John, Mark C Walters, Hemalatha G Rangarajan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 27, 2015
Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell DiseaseMark C Walters, Laura M De Castro, Keith M Sullivan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemiaJohn T Horan, Jeanette Carreras, Sergey Tarima, et al.
Cell Stem Cell|June 3, 2018
CIRM Alpha Stem Cell Clinics: Collaboratively Addressing Regenerative Medicine ChallengesCatriona H M Jamieson, Maria T Millan, Abla A Creasey, et al.
Blood|September 11, 2007
A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) studyHaydar Frangoul, Eneida R Nemecek, Dean Billheimer, et al.
Plos One|January 16, 2019
CRISPR-Cas9 interrogation of a putative fetal globin repressor in human erythroid cellsJennifer E Chung, Wendy Magis, Jonathan Vu, et al.
The New England Journal of Medicine|April 3, 2026
CRISPR-Cas12a Gene Editing of <i>HBG1</i> and <i>HBG2</i> Promoters to Treat β-ThalassemiaHaydar Frangoul, Rabi Hanna, Mark C Walters, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Annals of the New York Academy of Sciences|December 13, 2005
Sibling donor cord blood transplantation for thalassemia major: Experience of the Sibling Donor Cord Blood ProgramMark C Walters, Lynn Quirolo, Elizabeth T Trachtenberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2017
Relationship between Mixed Donor-Recipient Chimerism and Disease Recurrence after Hematopoietic Cell Transplantation for Sickle Cell DiseaseAllistair Abraham, Matthew Hsieh, Mary Eapen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2003
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemiaRobert Iannone, James F Casella, Ephraim J Fuchs, et al.
Blood Advances|October 7, 2024
Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell diseaseTami D John, Mark C Walters, Hemalatha G Rangarajan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 27, 2015
Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell DiseaseMark C Walters, Laura M De Castro, Keith M Sullivan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2009
Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemiaJohn T Horan, Jeanette Carreras, Sergey Tarima, et al.
Cell Stem Cell|June 3, 2018
CIRM Alpha Stem Cell Clinics: Collaboratively Addressing Regenerative Medicine ChallengesCatriona H M Jamieson, Maria T Millan, Abla A Creasey, et al.
Blood|September 11, 2007
A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) studyHaydar Frangoul, Eneida R Nemecek, Dean Billheimer, et al.
Plos One|January 16, 2019
CRISPR-Cas9 interrogation of a putative fetal globin repressor in human erythroid cellsJennifer E Chung, Wendy Magis, Jonathan Vu, et al.
The New England Journal of Medicine|April 3, 2026
CRISPR-Cas12a Gene Editing of <i>HBG1</i> and <i>HBG2</i> Promoters to Treat β-ThalassemiaHaydar Frangoul, Rabi Hanna, Mark C Walters, et al.
Pageof 9